Final report of a prospective randomized study on thoracic radiotherapy target volumes for limited-stage small cell lung cancer

医学 放射治疗 预防性头颅照射 肺癌 阶段(地层学) 化疗 随机对照试验 前瞻性队列研究 外科 淋巴结 内科学 古生物学 心肌梗塞 传统PCI 生物
作者
Xiao Hu,Yong Bao,Yujin Xu,Li Zhang,Jin Wang,Honglian Ma,Ying Jin,Xiaoling Xu,Zhengbo Song,Fang Peng,Huarong Tang,Min Fang,Yue Kong,Mengyuan Chen,Baiqiang Dong,Xinmin Yu,Hongyang Lu,Yiping Zhang,Yun Fan,Ming Chen
出处
期刊:Chinese Journal of Radiation Oncology [Chinese Medical Association]
卷期号:27 (12): 1046-1050
标识
DOI:10.3760/cma.j.issn.1004-4221.2018.12.003
摘要

Objective In view of the controversy over radiotherapy target volume for patients with limited-stage small cell lung cancer (SCLC), a prospective randomized controlled trial was conducted to compare the impact of different radiotherapy target volumes on prognosis. Methods After 2 cycles of EP chemotherapy, patients without progressive disease were randomly assigned to receive thoracic radiotherapy (TRT) to either the post-or pre-chemotherapy primary tumour extent as study arm or control. Involved field radiotherapy (IFRT) to the entire metastatic lymph node regions was applied for both arms. TRT consisted of 45 Gy/30Fx/19 d administered concurrently with cycle 3 chemotherapy. Prophylactic cranial irradiation was administered to patients achieved complete or partial remission. Kaplan-Meier method was used for survival analysis. Results Between June 2002 and December 2017, 159 and 150 patients were randomly assigned to study arm and control respectively. The 1-, 2-, and 5-year local/regional control rates were 79.4%, 61.5% and 60.1% respectively in the study arm versus 79.8%, 66.5%, and 57.3% in the control arm (P=0.73). The median OS time was 22.1 months in the study arm (95%CI, 18.2-26.0 months) and 26.9 months (95%CI, 23.5-30.3 months) in the control arm, the 1-, 3-, 5-, and 7-year OS rates were 81.1%, 31.6%, 23.9% and 22.2% respectively in the study arm versus 85.3%, 36.6%, 26.1% and 20.0% in the control arm (P=0.51). Grade 2-3 acute esophagitis was developed in 32.9% and 43.2% of patients respectively in study arm and control arm (P=0.01), while grade 2-3 pulmonary fibrosis was observed in 2.0% and 10.9% of patients (P=0.01) respectively. Conclusions For patients with limited-stage SCLC who received induction chemotherapy, thoracic radiotherapy can be limited to post-chemotherapy tumour extent and IFRT can be routinely applied. Key words: Lung neoplasms/radiotherapy; Radiotherapy target volume; Prospective study
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ZZZ完成签到,获得积分10
刚刚
1秒前
2秒前
缥缈的雁枫完成签到,获得积分10
2秒前
我是老大应助风清扬采纳,获得10
2秒前
李健应助风清扬采纳,获得10
2秒前
3秒前
ENEN发布了新的文献求助10
3秒前
4秒前
bkagyin应助Irvinga采纳,获得10
4秒前
6秒前
量子星尘发布了新的文献求助10
6秒前
7秒前
嘿嘿发布了新的文献求助10
7秒前
章传奇发布了新的文献求助20
8秒前
吴啊完成签到,获得积分10
8秒前
ZZZ发布了新的文献求助30
8秒前
小白关注了科研通微信公众号
9秒前
9秒前
chiu_yy发布了新的文献求助10
10秒前
10秒前
华仔应助卿卿采纳,获得10
10秒前
搜集达人应助完美的冬灵采纳,获得10
10秒前
gcy发布了新的文献求助10
11秒前
向阳完成签到,获得积分10
11秒前
11秒前
个性的紫菜应助FFFFFF采纳,获得100
11秒前
LM完成签到 ,获得积分10
12秒前
12秒前
13秒前
14秒前
shdheud发布了新的文献求助10
14秒前
pu完成签到 ,获得积分10
15秒前
15秒前
niu发布了新的文献求助10
15秒前
xx发布了新的文献求助10
15秒前
朱猪侠完成签到,获得积分10
16秒前
天天快乐应助ruby采纳,获得10
19秒前
复杂发布了新的文献求助10
19秒前
刚国忠完成签到,获得积分20
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Encyclopedia of Reproduction Third Edition 3000
Comprehensive Methanol Science Production, Applications, and Emerging Technologies 2000
化妆品原料学 1000
《药学类医疗服务价格项目立项指南(征求意见稿)》 1000
1st Edition Sports Rehabilitation and Training Multidisciplinary Perspectives By Richard Moss, Adam Gledhill 600
nephSAP® Nephrology Self-Assessment Program - Hypertension The American Society of Nephrology 500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5632327
求助须知:如何正确求助?哪些是违规求助? 4726681
关于积分的说明 14981762
捐赠科研通 4790262
什么是DOI,文献DOI怎么找? 2558238
邀请新用户注册赠送积分活动 1518646
关于科研通互助平台的介绍 1479089